{
  "id": 13126057,
  "title": "FDA approves Teva’s once-monthly schizophrenia treatment",
  "url": "https://urgent.news/2026/10/09/fda-approves-tevas-once-monthly-schizophrenia-treatment",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-09T13:07:02.000Z",
  "source": {
    "name": "Arutz Sheva - Israel National News",
    "slug": "arutz-sheva-israel-national-news",
    "url": "https://www.israelnationalnews.com/flashes/695059"
  },
  "original_language": "en",
  "account": null,
  "summary": "Israeli pharmaceutical giant Teva receives FDA approval for WELTRUZA, a new long-acting injection for schizophrenia that eliminates the need for daily medication.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}